PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Activus Solutions, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Activus Solutions to Sponsor the 2013 Revitas Industry Summit - Life Sciences in Philadelphia - Industry event will focus on the complex issues facing pharmaceutical and life sciences companies in contracting, pricing, and compliance - Revitasinc.com / ActivusSolutions.com
Activus Solutions to Sponsor the 2013 Revitas Industry Summit - Life Sciences in Philadelphia

 

NewswireToday - /newswire/ - Randolph, NJ, United States, 2013/10/01 - Industry event will focus on the complex issues facing pharmaceutical and life sciences companies in contracting, pricing, and compliance - Revitasinc.com / ActivusSolutions.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Today Activus Solutions announced it will be sponsoring the 2013 Revitas® Industry Summit: Life Sciences, the premier Enterprise Revenue Dynamics event for pharmaceutical and life sciences professionals, which takes place in Philadelphia on November 5-6, 2013 at the Four Seasons Hotel. The conference plans to bring together over 250 life sciences professionals to discuss upcoming industry changes, share proven best practices, and gain new insight from industry luminaries and thought leadership tracks.

This year, the Revitas Industry Summit: Life Sciences will address strategies for global revenue management within the ever-changing pharmaceutical landscape, the impact of the Affordable Care Act (ACA), and other regulatory and compliance changes in 2013 and beyond. Throughout the two days, attendees will be exposed to valuable perspectives in order to improve contract management, pricing execution, and compliance, as well as have the opportunity to network with and learn from industry leaders and peers.

Activus Solutions has provided exemplary consulting services solely to the Life-Sciences industry since 2003. Earlier this year, Activus and Revitas announced a successful joint effort that led to the on-time and within budget implementation of the Revitas® CARS® application with a leading generics manufacturer.

“We are excited to continue our long history of sponsoring this event,” said John J.K. Olson, Principal with Activus Solutions,“We support a significant number of clients that are using one or more applications within either the Revitas legacy or Flex® platform suite.”

“By sponsoring this event, Activus will continue to solidify our working partnership with Revitas and provide our clients with the top-level service that they expect from Activus Solutions, said John Taurozzi, Principal with Activus Solutions.”

“The life sciences landscape has seen significant change over the last year through the increased globalization of the healthcare system and new compliance and regulatory challenges impacting almost every facet of the industry,” said Al Smith, President and COO of Revitas. “Revitas will once again bring together customers, partners, and industry professionals who are all working to understand, prepare for, and manage these new requirements while improving financial outcomes. This year’s Summit offers attendees a forum to share global revenue management trends, strategies for emerging growth companies, and tactics for optimizing contracts, boosting revenue, and maintaining compliance.”

For more information about the 2013 Revitas Industry Summit: Life Sciences or to register for the event, please visit summit.revitasinc.com/.

About Revitas
Revitas (revitasinc.com), the leader in Enterprise Revenue Dynamics, delivers integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. Revitas empowers companies to optimize contract performance by defining, managing, and analyzing complex, multi-tier pricing incentives and enables positive proof of compliance with commercial, financial, and industry requirements. Powered by the secure, scalable, and standards-based Flex® platform, Revitas® applications speed time to market and improve visibility across B2B relationships. Hundreds of organizations across the most highly regulated and challenging industries leverage Revitas integrated solutions to save money, make money, and reduce risk. For details, visit revitasinc.com or blog.revitasinc.com.

About Activus Solutions, LLC
Activus Solutions (activussolutions.com) is a unique consulting firm solely focused on enabling Pharmaceutical Manufacturers to optimize their contract management processes. Over the past decade, Activus has brought unmatched business and technical expertise to over 50 manufacturers, performing efforts that include operational ‘best practice’ assessments, business process outsourcing services, software evaluations, comprehensive system implementations, and legacy system upgrades. For more information, please visit activussolutions.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Activus Solutions, LLC

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Activus Solutions to Sponsor the 2013 Revitas Industry Summit - Life Sciences in Philadelphia

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Chris Seichter - ActivusSolutions.com 
704-256-7002 cseichter[.]activussolutions.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Activus Solutions, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Activus Solutions, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)